Empty Capsules Market is projected to reach $5.36 billion by 2032, with a 5.37% CAGR fueled by demand for better drug delivery systems and clean-label supplements in nutraceutical and pharmaceutical sectors. U.S. market expected to reach $1.59 billion by 2032 due to favorable FDA regulations and personalized medicine trends.
Asia Pacific led the market in 2023, with a 42% revenue share, while North America was second with a 28% share. Recent developments include ACG’s plant upgrade in Croatia and Lonza’s acquisition of Roche’s biologics site. Qualicaps introduced a new acid-resistant capsule for probiotic supplements in 2024.
Gelatin capsules dominated the market in 2023 with 68% market share, while immediate release capsules accounted for 48% of revenue. Antibiotic and antibacterial drugs were the leading application segment with a 22% share, and the pharmaceutical industry was the major end-user with a 58% market share.
Major players in the market include Capsugel, ACG, QUALICAPS, and SUHEUNG, among others. The market is driven by rising demand for capsule-based antibiotics, dietary supplements, and functional formulations, as well as technological advancements in capsule filling machines and vegan-friendly production.
Unique Selling Propositions (USP) of the market research report include the Capsule Innovation Tracker, Raw Material Intelligence, Global regulatory compliance, Mapping Supply Chain Disruption, Sentiment Insights from End-Users, and Smart Pills and Digital Integration. Buyers can access the full report for detailed insights and analysis.
Read more at GlobeNewswire: Global Empty Capsules Market to Reach USD 5.36 Billion by